
Taofiq A Solola
Examiner (ID: 14120, Phone: (571)272-0709 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1626, 1625, 1622, 1613 |
| Total Applications | 3196 |
| Issued Applications | 2336 |
| Pending Applications | 272 |
| Abandoned Applications | 640 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13733031
[patent_doc_number] => 20180370983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 16/018924
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16018924
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/018924 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | Jun 25, 2018 | Issued |
Array
(
[id] => 16310744
[patent_doc_number] => 20200289482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/625419
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625419 | CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE | Jun 20, 2018 | Abandoned |
Array
(
[id] => 14731293
[patent_doc_number] => 10385035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Dinaphthothiophene compounds
[patent_app_type] => utility
[patent_app_number] => 16/013432
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4668
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16013432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/013432 | Dinaphthothiophene compounds | Jun 19, 2018 | Issued |
Array
(
[id] => 17281672
[patent_doc_number] => 11198692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Dihydro-pyrrolo-pyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/625202
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37076
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625202 | Dihydro-pyrrolo-pyridine derivatives | Jun 13, 2018 | Issued |
Array
(
[id] => 13478903
[patent_doc_number] => 20180290994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => OXIDATION PROCESS TO PRODUCE A PURIFIED CARBOXYLIC ACID PRODUCT VIA SOLVENT DISPLACEMENT AND POST OXIDATION
[patent_app_type] => utility
[patent_app_number] => 16/004549
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/004549 | OXIDATION PROCESS TO PRODUCE A PURIFIED CARBOXYLIC ACID PRODUCT VIA SOLVENT DISPLACEMENT AND POST OXIDATION | Jun 10, 2018 | Abandoned |
Array
(
[id] => 15338731
[patent_doc_number] => 10525019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Methods of treating diseases associated with high-fat diet and vitamin a deficiency using retinoic acid receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/000003
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 24
[patent_no_of_words] => 17922
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000003 | Methods of treating diseases associated with high-fat diet and vitamin a deficiency using retinoic acid receptor agonists | Jun 4, 2018 | Issued |
Array
(
[id] => 16998315
[patent_doc_number] => 11077097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Use of aromatic ring drug in inhibiting key transcription factor of malignant melanoma
[patent_app_type] => utility
[patent_app_number] => 16/627144
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4065
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627144 | Use of aromatic ring drug in inhibiting key transcription factor of malignant melanoma | Jun 3, 2018 | Issued |
Array
(
[id] => 14852057
[patent_doc_number] => 10414740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Glutaminase inhibitors and method of use
[patent_app_type] => utility
[patent_app_number] => 15/996723
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27041
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996723 | Glutaminase inhibitors and method of use | Jun 3, 2018 | Issued |
Array
(
[id] => 13457649
[patent_doc_number] => 20180280367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS
[patent_app_type] => utility
[patent_app_number] => 15/996951
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996951
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996951 | USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS | Jun 3, 2018 | Abandoned |
Array
(
[id] => 14227129
[patent_doc_number] => 20190125737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/994005
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994005
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994005 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | May 30, 2018 | Abandoned |
Array
(
[id] => 13504625
[patent_doc_number] => 20180303855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => COMPOSITION AND METHODS OF USE OF SMALL MOLECULES AS BINDING LIGANDS FOR THE MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9(PCSK9) PROTEIN ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/989360
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989360
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989360 | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity | May 24, 2018 | Issued |
Array
(
[id] => 15678343
[patent_doc_number] => 20200093835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHODS OF TREATING VESTIBULAR SCHWANNOMA
[patent_app_type] => utility
[patent_app_number] => 16/612317
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612317 | METHODS OF TREATING VESTIBULAR SCHWANNOMA | May 22, 2018 | Abandoned |
Array
(
[id] => 15990303
[patent_doc_number] => 20200171022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => FLT3 INHIBITORS FOR IMPROVING PAIN TREATMENTS BY OPIOIDS
[patent_app_type] => utility
[patent_app_number] => 16/613859
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613859 | FLT3 INHIBITORS FOR IMPROVING PAIN TREATMENTS BY OPIOIDS | May 16, 2018 | Abandoned |
Array
(
[id] => 16086795
[patent_doc_number] => 20200197384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => TREATMENT OF HEPATOCELLULAR CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 16/609895
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609895 | TREATMENT OF HEPATOCELLULAR CARCINOMA | May 14, 2018 | Abandoned |
Array
(
[id] => 13618387
[patent_doc_number] => 20180360745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => METHOD OF TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/978742
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978742
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978742 | Method of treating disease | May 13, 2018 | Issued |
Array
(
[id] => 15962947
[patent_doc_number] => 20200165225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => BACE1 INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/626717
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626717 | BACE1 INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | May 7, 2018 | Abandoned |
Array
(
[id] => 14551141
[patent_doc_number] => 10344011
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-07-09
[patent_title] => Furan-2,5-dicarboxylic acid purge process
[patent_app_type] => utility
[patent_app_number] => 15/971106
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8171
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 318
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971106 | Furan-2,5-dicarboxylic acid purge process | May 3, 2018 | Issued |
Array
(
[id] => 17420071
[patent_doc_number] => 11253500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection
[patent_app_type] => utility
[patent_app_number] => 16/611908
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8096
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611908 | Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection | May 3, 2018 | Issued |
Array
(
[id] => 16008983
[patent_doc_number] => 20200179334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING ENDOMETRIOSIS AND ENDOMETRIOSIS ASSOCIATED SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 16/609413
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609413 | METHODS AND COMPOSITIONS FOR TREATING ENDOMETRIOSIS AND ENDOMETRIOSIS ASSOCIATED SYMPTOMS | May 2, 2018 | Abandoned |
Array
(
[id] => 14005435
[patent_doc_number] => 10221153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Dibenzothiophene compounds
[patent_app_type] => utility
[patent_app_number] => 15/970584
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 10266
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970584
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970584 | Dibenzothiophene compounds | May 2, 2018 | Issued |